Selling a Dermatology Practice Business in Savannah, GA — Buyers, Multiples & What to Expect

Dermatology practices in Savannah, GA are selling at 5x-10x EBITDA in 2026, with multi-provider practices combining medical, Mohs, and cosmetic revenue reaching the high end of that range. The Savannah MSA covers roughly 1,070,180 people as of the April 2025 PopStats estimate, with a 5.8% five-year population forecast. Healthcare generated approximately $2 billion of personal income in the MSA in 2023 — about 8% of total regional personal income. Memorial University Medical Center and St. Joseph's/Candler Health System are the two largest private nonmanufacturing employers, creating deep clinical referral infrastructure for specialty practices.

At a Glance — Savannah, GA

  • 5.0x-10.0x EBITDA: Typical Multiple Range
  • Epiphany, ADCS, USDP, Forefront + Regional PE: Active Buyers
  • 6-12 Months: Typical Timeline
  • $800K-$5M EBITDA: Sweet Spot

What Makes Savannah's Dermatology Market Different?

Savannah's market has three characteristics that shape valuations. First, demographics — the Savannah MSA is forecasted to grow 5.8% over the next five years, and Chatham County's skin cancer incidence tracks above national averages given Georgia's sun exposure patterns, creating structural demand for dermatology services. Second, employer anchors — Memorial Health and St. Joseph's/Candler anchor roughly 8% of regional personal income, while the Port of Savannah (one of the fastest-growing U.S. ports), Gulfstream Aerospace, Hunter Army Airfield, Fort Stewart, and the tourism economy provide a layered commercial payor base with durable insurance coverage across manufacturing, logistics, military, hospitality, and retail. Third, Savannah's I-95 corridor position between Charleston, Jacksonville, and the Atlanta metro makes it an attractive target for regional dermatology platforms building Southeast coastal networks.

The tourism and retiree economy also matter for cosmetic dermatology — Savannah draws a large aesthetic cash-pay population, both from tourism (Hilton Head, Tybee Island, and the historic district) and from retirement communities on the coast. Practices with well-developed cosmetic and medical spa lines get strong credit for that cash-pay exposure. Owners considering a sale should review the dermatology valuation framework alongside the Savannah market hub.

Who's Buying Dermatology Practices in Savannah?

Active acquirers include Epiphany Dermatology (39 deals over five years, highly active in the Southeast), Advanced Dermatology & Cosmetic Surgery (ADCS), US Dermatology Partners, Forefront Dermatology, Schweiger Dermatology Group, and Dermatology Associates of the Lowcountry (regional). PE-backed platforms from LGP Capital, Harvest Partners, Morgan Stanley Capital Partners, New MainStream Capital, and Audax Group have closed Southeast add-ons in recent quarters. Atlanta-based and Charleston-based regional platforms specifically target Savannah as a coastal expansion node.

Memorial Health and St. Joseph's/Candler periodically acquire physician practices to anchor referral networks, though their focus is typically on primary care and specialties complementary to hospital service lines rather than dermatology specifically. For most independent Savannah dermatology sellers, the realistic buyer pool is 5-8 PE-backed and strategic platform bidders, with competitive processes commonly producing 3-5 LOIs in practices above $1M EBITDA.

What Do Dermatology Practices Sell For in Savannah?

Savannah dermatology multiples run slightly below Richmond's — reflecting a smaller metro and thinner commercial payor base — but platform-quality assets still reach the high end of the national range. A single-provider practice with $300K-$500K EBITDA typically sells at 3x-5x. A small group with $600K-$1.2M EBITDA and a Mohs capability reaches 5x-8x. Multi-provider practices with $1.2M-$3M EBITDA, diversified revenue mix, and non-owner provider leverage command 7x-10x. Practices with multiple coastal locations (Savannah, Richmond Hill, Pooler, Hinesville, Bluffton just across the SC line) and $3M+ EBITDA can reach 10x-12x in the current market.

Mohs-heavy practices earn a premium because Georgia's skin cancer incidence drives structural demand. Cosmetic-heavy practices serving the tourism and retiree population get strong credit for recurring membership revenue and high-margin aesthetic procedures. The sweet spot is $800K-$2.5M EBITDA with at least one Mohs surgeon, at least one recruited associate, and a visible cosmetic business line.

What Do Savannah Dermatology Owners Need to Know?

Three things specific to the Savannah/coastal Georgia market. First, Anthem BCBS of Georgia is the dominant commercial payor, with Aetna, UHC, and Cigna making up the balance — buyers will scrutinize rates and credentialing status with all four. Second, Georgia's Medicaid managed care structure (Amerigroup, CareSource, Peach State, Wellcare of Georgia) applies to any Medicaid volume — most dermatology practices run minimal Medicaid, but if yours is heavier than 10% of visits, you'll want to have MCO contract status documented before diligence. Third, Memorial Health and St. Joseph's/Candler referral relationships are high-value signals for buyers — if your practice has documented inbound referral patterns from Savannah hospital systems, make sure that's captured in your CIM, because it directly supports the buyer's view of demand durability.

"A Savannah dermatology practice I took to market in early 2025 — two physicians, Mohs capability, one cosmetic PA, $1.1M EBITDA, 55% medical / 20% Mohs / 25% cosmetic, strong Anthem GA and Aetna contracts — closed at 7.9x EBITDA with a Southeast-focused PE platform. The cosmetic cash-pay visibility in Savannah is real, and buyers pay for it — tourism and retiree exposure gives cosmetic practices here a durability story that buyers in less-visited metros don't get. Coastal Georgia remains one of the most underappreciated dermatology markets in the Southeast."

— John M. Salony, Business Broker

Find Out What Your Business Is Worth in Savannah

Start with the free valuation calculator to see what your Savannah practice is worth in today's market. From there we can set up a confidential consultation to walk through Mohs, cosmetic, and commercial payor levers specific to your practice.

Schedule a Confidential Consultation

Frequently Asked Questions

What Makes Savannah's Dermatology Market Different?
Savannah's market has three characteristics that shape valuations. First, demographics — the Savannah MSA is forecasted to grow 5.8% over the next five years, and Chatham County's skin cancer incidence tracks above national averages given Georgia's sun exposure patterns. Second, employer anchors — Memorial Health and St. Joseph's/Candler anchor roughly 8% of regional personal income, while the Port of Savannah, Gulfstream Aerospace, Hunter Army Airfield, Fort Stewart, and the tourism economy provide a layered commercial payor base with durable insurance coverage across manufacturing, logistics, military, hospitality, and retail. Third, Savannah's I-95 corridor position between Charleston, Jacksonville, and Atlanta makes it an attractive target for regional dermatology platforms building Southeast coastal networks. The tourism and retiree economy supports a large aesthetic cash-pay population from Hilton Head, Tybee Island, and coastal retirement communities.
Who's Buying Dermatology Practices in Savannah?
Active acquirers include Epiphany Dermatology (39 deals over five years, highly active in the Southeast), Advanced Dermatology & Cosmetic Surgery (ADCS), US Dermatology Partners, Forefront Dermatology, Schweiger Dermatology Group, and Dermatology Associates of the Lowcountry (regional). PE-backed platforms from LGP Capital, Harvest Partners, Morgan Stanley Capital Partners, New MainStream Capital, and Audax Group have closed Southeast add-ons in recent quarters. Atlanta-based and Charleston-based regional platforms specifically target Savannah as a coastal expansion node. Memorial Health and St. Joseph's/Candler periodically acquire physician practices to anchor referral networks, though their focus is typically primary care and hospital-complementary specialties rather than dermatology. For most independent Savannah sellers, the realistic buyer pool is 5-8 PE-backed and strategic platform bidders, with competitive processes commonly producing 3-5 LOIs in practices above $1M EBITDA.
What Do Dermatology Practices Sell For in Savannah?
Savannah dermatology multiples run slightly below Richmond's — reflecting a smaller metro and thinner commercial payor base — but platform-quality assets still reach the high end of national ranges. A single-provider practice with $300K-$500K EBITDA typically sells at 3x-5x. A small group with $600K-$1.2M EBITDA and a Mohs capability reaches 5x-8x. Multi-provider practices with $1.2M-$3M EBITDA, diversified revenue mix, and non-owner provider leverage command 7x-10x. Practices with multiple coastal locations — Savannah, Richmond Hill, Pooler, Hinesville, Bluffton just across the SC line — and $3M+ EBITDA can reach 10x-12x. Mohs-heavy practices earn a premium because Georgia's skin cancer incidence drives structural demand. Cosmetic-heavy practices serving the tourism and retiree population get strong credit for recurring membership revenue and high-margin aesthetic procedures.
What Do Savannah Dermatology Owners Need to Know?
Three things specific to the Savannah/coastal Georgia market. First, Anthem BCBS of Georgia is the dominant commercial payor, with Aetna, UHC, and Cigna making up the balance — buyers will scrutinize rates and credentialing status with all four. Second, Georgia's Medicaid managed care structure (Amerigroup, CareSource, Peach State, Wellcare of Georgia) applies to any Medicaid volume — most dermatology practices run minimal Medicaid, but if yours is heavier than 10% of visits, you'll want to have MCO contract status documented before diligence. Third, Memorial Health and St. Joseph's/Candler referral relationships are high-value signals for buyers — if your practice has documented inbound referral patterns from Savannah hospital systems, make sure that's captured in the CIM because it supports the buyer's view of demand durability.